| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.798 | 0.004 | 0.798 | Anticonvulsant | 0.189 0.091 DBMET00451 | ||
| 0.774 | 0.001 | 0.774 | Mineralocorticoid receptor antagonist | 0.482 0.003 DBMET00451 | ||
| 0.685 | 0.005 | 0.685 | Cardiotonic | 0.434 0.023 DBMET00451 | ||
| 0.532 | 0.004 | 0.532 | Glutamate (mGluR) agonist | 0.345 0.005 DBMET00451 | ||
| 0.533 | 0.04 | 0.533 | Analgesic | |||
| 0.498 | 0.051 | 0.498 | Cyclophilin D inhibitor | |||
| 0.469 | 0.035 | 0.469 | GABA C receptor rho-3 antagonist | 0.451 0.041 DBMET00451 | ||
| 0.332 | 0.026 | 0.414 | RNA-directed DNA polymerase inhibitor | 0.414 0.017 DBMET00451 | DBMET00451 | |
| 0.377 | 0.094 | 0.486 | 5 Hydroxytryptamine release inhibitor | 0.486 0.037 DBMET00451 | DBMET00451 | |
| 0.282 | 0.005 | 0.282 | Glutamate receptor agonist | 0.136 0.021 DBMET00451 | ||
| 0.27 | 0.028 | 0.27 | Diuretic | 0.143 0.083 DBMET00451 | ||
| 0.245 | 0.014 | 0.245 | Ferrochelatase inhibitor | 0.221 0.018 DBMET00451 | ||
| 0.274 | 0.061 | 0.274 | 5 Hydroxytryptamine uptake stimulant | 0.26 0.072 DBMET00451 | ||
| 0.352 | 0.148 | 0.352 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.346 0.155 DBMET00451 | ||
| 0.206 | 0.005 | 0.206 | Bromodomain-containing protein 4 inhibitor | |||
| 0.313 | 0.117 | 0.371 | Histamine release inhibitor | 0.371 0.09 DBMET00451 | DBMET00451 | |
| 0.257 | 0.062 | 0.277 | Tyrosine 3 hydroxylase inhibitor | 0.277 0.046 DBMET00451 | DBMET00451 | |
| 0.198 | 0.008 | 0.198 | Phosphodiesterase 3A inhibitor | 0.151 0.015 DBMET00451 | ||
| 0.204 | 0.016 | 0.204 | Cathepsin G inhibitor | 0.108 0.03 DBMET00451 | ||
| 0.19 | 0.004 | 0.19 | Glutamate (mGluR group II) agonist | 0.03 0.029 DBMET00451 | ||
| 0.184 | 0.004 | 0.184 | Glutamate (mGluR2) agonist | |||
| 0.215 | 0.041 | 0.215 | 5 Hydroxytryptamine 3E antagonist | 0.204 0.055 DBMET00451 | ||
| 0.203 | 0.033 | 0.386 | Alpha-N-acetylglucosaminidase inhibitor | 0.386 0.01 DBMET00451 | DBMET00451 | |
| 0.241 | 0.073 | 0.286 | DNA synthesis inhibitor | 0.286 0.048 DBMET00451 | DBMET00451 | |
| 0.271 | 0.114 | 0.271 | Vasodilator, coronary | 0.232 0.152 DBMET00451 | ||
| 0.162 | 0.005 | 0.162 | Aldosterone antagonist | 0.086 0.01 DBMET00451 | ||
| 0.218 | 0.061 | 0.239 | Neurotrophic factor enhancer | 0.239 0.045 DBMET00451 | DBMET00451 | |
| 0.226 | 0.07 | 0.226 | Peptidyltransferase inhibitor | 0.197 0.103 DBMET00451 | ||
| 0.166 | 0.016 | 0.172 | Ca2+-transporting ATPase inhibitor | 0.172 0.012 DBMET00451 | DBMET00451 | |
| 0.172 | 0.024 | 0.172 | Bronchodilator | 0.141 0.034 DBMET00451 | ||
| 0.148 | 0.006 | 0.148 | Protein kinase C epsilon inhibitor | |||
| 0.151 | 0.01 | 0.151 | Phosphodiesterase III inhibitor | 0.072 0.042 DBMET00451 | ||
| 0.233 | 0.101 | 0.233 | Gastrin inhibitor | 0.191 0.162 DBMET00451 | ||
| 0.165 | 0.041 | 0.201 | Adenylate cyclase stimulant | 0.201 0.013 DBMET00451 | DBMET00451 | |
| 0.13 | 0.007 | 0.13 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | 0.043 0.037 DBMET00451 | ||
| 0.223 | 0.104 | 0.223 | Spasmolytic | |||
| 0.134 | 0.017 | 0.155 | HIV-1 reverse transcriptase inhibitor | 0.155 0.013 DBMET00451 | DBMET00451 | |
| 0.138 | 0.028 | 0.138 | Prolactin inhibitor | 0.108 0.048 DBMET00451 | ||
| 0.113 | 0.007 | 0.113 | Elastase inhibitor | 0.051 0.04 DBMET00451 | ||
| 0.113 | 0.009 | 0.113 | Phosphodiesterase 3B inhibitor | 0.107 0.01 DBMET00451 | ||
| 0.251 | 0.146 | 0.298 | Calcium channel activator | 0.298 0.093 DBMET00451 | DBMET00451 | |
| 0.108 | 0.007 | 0.108 | Glutamate (mGluR7) antagonist | 0.09 0.018 DBMET00451 | ||
| 0.106 | 0.009 | 0.106 | Progesterone antagonist | 0.041 0.022 DBMET00451 | ||
| 0.104 | 0.006 | 0.104 | Glutamate (mGluR5) agonist | 0.065 0.015 DBMET00451 | ||
| 0.104 | 0.008 | 0.104 | Glutamate (mGluR group I) agonist | 0.074 0.014 DBMET00451 | ||
| 0.158 | 0.064 | 0.162 | GABA C receptor rho-2 antagonist | 0.162 0.059 DBMET00451 | DBMET00451 | |
| 0.108 | 0.016 | 0.108 | Acetylcholine M5 receptor agonist | |||
| 0.117 | 0.025 | 0.117 | Bromodomain-containing protein 2 inhibitor | |||
| 0.229 | 0.14 | 0.306 | Cholesterol antagonist | 0.306 0.087 DBMET00451 | DBMET00451 | |
| 0.183 | 0.096 | 0.183 | Histone acetyltransferase inhibitor | |||
| 0.112 | 0.037 | 0.172 | Triose-phosphate isomerase inhibitor | 0.172 0.015 DBMET00451 | DBMET00451 | |
| 0.169 | 0.096 | 0.17 | Anesthetic general | 0.17 0.095 DBMET00451 | DBMET00451 | |
| 0.095 | 0.022 | 0.151 | Carbamoyl phosphate synthetase inhibitor | 0.151 0.011 DBMET00451 | DBMET00451 | |
| 0.161 | 0.091 | 0.161 | Lipocortins synthesis antagonist | 0.14 0.121 DBMET00451 | ||
| 0.112 | 0.049 | 0.164 | UDP-glucose 4-epimerase inhibitor | 0.164 0.024 DBMET00451 | DBMET00451 | |
| 0.139 | 0.077 | 0.139 | Pregnane X receptor agonist | 0.134 0.088 DBMET00451 | ||
| 0.15 | 0.088 | 0.197 | Arachidonic acid antagonist | 0.197 0.036 DBMET00451 | DBMET00451 | |
| 0.067 | 0.008 | 0.067 | Prostaglandin EP3 antagonist | |||
| 0.161 | 0.101 | 0.161 | P-glycoprotein inhibitor | |||
| 0.081 | 0.022 | 0.081 | Calcium channel T-type blocker | |||
| 0.07 | 0.012 | 0.087 | Adenylate cyclase 1 inhibitor | 0.087 0.006 DBMET00451 | DBMET00451 | |
| 0.132 | 0.075 | 0.132 | Calcium channel blocker | |||
| 0.138 | 0.082 | 0.138 | Heat shock protein 70 antagonist | 0.132 0.112 DBMET00451 | ||
| 0.101 | 0.046 | 0.109 | Androgen antagonist | 0.109 0.04 DBMET00451 | DBMET00451 | |
| 0.076 | 0.021 | 0.076 | Protein 50S ribosomal subunit inhibitor | 0.068 0.025 DBMET00451 | ||
| 0.06 | 0.007 | 0.06 | Calcitonin gene-related peptide antagonist | |||
| 0.131 | 0.079 | 0.131 | Nav1.6 sodium channel blocker | |||
| 0.151 | 0.1 | 0.188 | ATPase inhibitor | 0.188 0.048 DBMET00451 | DBMET00451 | |
| 0.098 | 0.046 | 0.098 | Acetylcholine M3 receptor agonist | |||
| 0.155 | 0.104 | 0.241 | Succinate dehydrogenase inhibitor | 0.241 0.026 DBMET00451 | DBMET00451 | |
| 0.106 | 0.055 | 0.135 | Anabolic | 0.135 0.027 DBMET00451 | DBMET00451 | |
| 0.063 | 0.015 | 0.063 | Carnitine palmitoyltransferase 1B inhibitor | 0.056 0.021 DBMET00451 | ||
| 0.076 | 0.03 | 0.124 | Glutamate (mGluR6) antagonist | 0.124 0.005 DBMET00451 | DBMET00451 | |
| 0.095 | 0.05 | 0.142 | NADH dehydrogenase inhibitor | 0.142 0.02 DBMET00451 | DBMET00451 | |
| 0.133 | 0.09 | 0.283 | Dual specificity tyrosine-phosphorylation-regulated kinase 4 inhibitor | 0.283 0.03 DBMET00451 | DBMET00451 | |
| 0.07 | 0.03 | 0.087 | Androgen agonist | 0.087 0.02 DBMET00451 | DBMET00451 | |
| 0.108 | 0.069 | 0.122 | Cystathionine beta-synthase inhibitor | 0.122 0.057 DBMET00451 | DBMET00451 | |
| 0.165 | 0.126 | 0.255 | Aldehyde oxidase inhibitor | 0.255 0.08 DBMET00451 | DBMET00451 | |
| 0.268 | 0.231 | 0.355 | Caspase 9 stimulant | 0.355 0.142 DBMET00451 | DBMET00451 | |
| 0.109 | 0.071 | 0.109 | Calcium channel (voltage-sensitive) blocker | |||
| 0.08 | 0.043 | 0.08 | Lipase inhibitor | |||
| 0.052 | 0.017 | 0.052 | Renin inhibitor | |||
| 0.101 | 0.066 | 0.149 | Adenylate kinase inhibitor | 0.149 0.027 DBMET00451 | DBMET00451 | |
| 0.097 | 0.062 | 0.108 | Electrolyte absorption antagonist | 0.108 0.047 DBMET00451 | DBMET00451 | |
| 0.06 | 0.026 | 0.071 | Alpha-mannosidase inhibitor | 0.071 0.016 DBMET00451 | DBMET00451 | |
| 0.084 | 0.051 | 0.107 | Glycine receptor antagonist | 0.107 0.026 DBMET00451 | DBMET00451 | |
| 0.082 | 0.049 | 0.1 | Na+ K+ transporting ATPase inhibitor | 0.1 0.031 DBMET00451 | DBMET00451 | |
| 0.104 | 0.071 | 0.104 | Protein kinase C gamma inhibitor | |||
| 0.065 | 0.033 | 0.065 | Potassium channel intermediate-conductance Ca-activated blocker | |||
| 0.056 | 0.025 | 0.056 | Bromodomain-containing protein 3 inhibitor | |||
| 0.108 | 0.077 | 0.13 | Microtubule formation inhibitor | 0.13 0.051 DBMET00451 | DBMET00451 | |
| 0.061 | 0.032 | 0.096 | Acyl-CoA dehydrogenase inhibitor | 0.096 0.017 DBMET00451 | DBMET00451 | |
| 0.124 | 0.096 | 0.372 | Peroxidase inhibitor | 0.372 0.025 DBMET00451 | DBMET00451 | |
| 0.083 | 0.056 | 0.087 | Estrogen-related receptor beta agonist | 0.087 0.046 DBMET00451 | DBMET00451 | |
| 0.033 | 0.006 | 0.033 | Acid ceramidase inhibitor | |||
| 0.2 | 0.176 | 0.202 | Vasodilator, peripheral | 0.202 0.173 DBMET00451 | DBMET00451 | |
| 0.172 | 0.148 | 0.223 | Nitric-oxide synthase stimulant | 0.223 0.056 DBMET00451 | DBMET00451 | |
| 0.07 | 0.048 | 0.142 | Phosphofructokinase-1 inhibitor | 0.142 0.02 DBMET00451 | DBMET00451 | |
| 0.095 | 0.073 | 0.296 | GABA C receptor agonist | 0.296 0.01 DBMET00451 | DBMET00451 | |
| 0.061 | 0.039 | 0.104 | Biliverdin reductase inhibitor | 0.104 0.017 DBMET00451 | DBMET00451 | |
| 0.065 | 0.044 | 0.065 | Protease 3C (Human rhinovirus) inhibitor | |||
| 0.091 | 0.071 | 0.12 | Creatine kinase inhibitor | 0.12 0.041 DBMET00451 | DBMET00451 | |
| 0.156 | 0.136 | 0.203 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | 0.203 0.069 DBMET00451 | DBMET00451 | |
| 0.049 | 0.03 | 0.076 | Glucose-6-phosphate isomerase inhibitor | 0.076 0.01 DBMET00451 | DBMET00451 | |
| 0.067 | 0.048 | 0.067 | MDM2 inhibitor | |||
| 0.05 | 0.032 | 0.05 | HCV NS3/NS4A protease inhibitor | 0.046 0.039 DBMET00451 | ||
| 0.055 | 0.038 | 0.055 | Acetylcholine muscarinic agonist | |||
| 0.028 | 0.014 | 0.028 | Toll-Like receptor 4 agonist | |||
| 0.07 | 0.056 | 0.109 | Glutamate dehydrogenase inhibitor | 0.109 0.026 DBMET00451 | DBMET00451 | |
| 0.098 | 0.084 | 0.098 | Anesthetic local | |||
| 0.07 | 0.055 | 0.097 | Glycine receptor agonist | 0.097 0.023 DBMET00451 | DBMET00451 | |
| 0.097 | 0.083 | 0.172 | GABA C receptor antagonist | 0.172 0.02 DBMET00451 | DBMET00451 | |
| 0.038 | 0.024 | 0.038 | Delayed rectifier potassium channel blocker | |||
| 0.168 | 0.155 | 0.168 | 5 Hydroxytryptamine release stimulant | |||
| 0.125 | 0.113 | 0.169 | Growth hormone agonist | 0.169 0.074 DBMET00451 | DBMET00451 | |
| 0.113 | 0.101 | 0.122 | Protein kinase stimulant | 0.122 0.091 DBMET00451 | DBMET00451 | |
| 0.043 | 0.034 | 0.058 | Mannosidase inhibitor | 0.058 0.018 DBMET00451 | DBMET00451 | |
| 0.09 | 0.081 | 0.09 | Falcipain 3 inhibitor | |||
| 0.04 | 0.032 | 0.04 | Acetylcholine M1 receptor agonist | |||
| 0.093 | 0.085 | 0.093 | 5 Hydroxytryptamine 3A agonist | |||
| 0.054 | 0.047 | 0.066 | Pregnane X receptor antagonist | 0.066 0.019 DBMET00451 | DBMET00451 | |
| 0.051 | 0.047 | 0.106 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.106 0.013 DBMET00451 | DBMET00451 | |
| 0.046 | 0.041 | 0.046 | Cytokine production stimulant | 0.046 0.041 DBMET00451 | ||
| 0.036 | 0.032 | 0.036 | Substance P antagonist | |||
| 0.044 | 0.04 | 0.056 | Cholesterol esterase inhibitor | 0.056 0.022 DBMET00451 | DBMET00451 | |
| 0.012 | 0.008 | 0.012 | 3C-Like protease (MERS coronavirus) inhibitor | |||
| 0.059 | 0.056 | 0.064 | Beta 2 adrenoreceptor agonist | 0.064 0.035 DBMET00451 | DBMET00451 | |
| 0.087 | 0.084 | 0.107 | GABA C receptor rho-1 antagonist | 0.107 0.054 DBMET00451 | DBMET00451 | |
| 0.038 | 0.036 | 0.049 | Leukocyte elastase inhibitor | 0.049 0.024 DBMET00451 | DBMET00451 | |
| 0.069 | 0.068 | 0.069 | Vanilloid 4 agonist | |||
| 0.027 | 0.026 | 0.027 | Glutamate (mGluR2) antagonist | |||
| 0.028 | 0.033 | 0.049 | Fumarate hydratase inhibitor | 0.049 0.014 DBMET00451 | DBMET00451 | |
| 0.079 | 0.084 | 0.112 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.112 0.044 DBMET00451 | DBMET00451 | |
| 0.025 | 0.034 | 0.029 | Estradiol 17 beta-dehydrogenase 3 inhibitor | 0.029 0.027 DBMET00451 | DBMET00451 | |
| 0.013 | 0.024 | 0.02 | Telomerase stimulant | 0.02 0.008 DBMET00451 | DBMET00451 | |
| 0.021 | 0.033 | 0.026 | Vanilloid 2 agonist | 0.026 0.016 DBMET00451 | DBMET00451 | |
| 0.086 | 0.101 | 0.113 | Mucolytic | 0.113 0.061 DBMET00451 | DBMET00451 | |
| 0.015 | 0.032 | 0.017 | Methylmalonyl-CoA mutase inhibitor | 0.017 0.015 DBMET00451 | DBMET00451 | |
| 0.034 | 0.052 | 0.051 | Kainate receptor agonist | 0.051 0.013 DBMET00451 | DBMET00451 | |
| 0.122 | 0.14 | 0.176 | CF transmembrane conductance regulator agonist | 0.176 0.04 DBMET00451 | DBMET00451 | |
| 0.015 | 0.035 | 0.023 | Glutamate (mGluR1a) agonist | 0.023 0.014 DBMET00451 | DBMET00451 | |
| 0.041 | 0.062 | 0.082 | Argininosuccinate synthase inhibitor | 0.082 0.025 DBMET00451 | DBMET00451 | |
| 0.022 | 0.043 | 0.035 | Purinergic P2Y15 antagonist | 0.035 0.011 DBMET00451 | DBMET00451 | |
| 0.081 | 0.105 | 0.109 | Adenylate cyclase inhibitor | 0.109 0.077 DBMET00451 | DBMET00451 | |
| 0.071 | 0.098 | 0.082 | mTOR complex 2 inhibitor | 0.082 0.064 DBMET00451 | DBMET00451 | |
| 0.013 | 0.043 | 0.018 | Antibiotic Anthracycline-like | 0.018 0.015 DBMET00451 | DBMET00451 | |
| 0.012 | 0.044 | 0.028 | Hypoxanthine phosphoribosyltransferase inhibitor | 0.028 0.019 DBMET00451 | DBMET00451 | |
| 0.077 | 0.109 | 0.091 | Bile acid receptor antagonist | 0.091 0.07 DBMET00451 | DBMET00451 | |
| 0.05 | 0.083 | 0.139 | Porphobilinogen synthase inhibitor | 0.139 0.023 DBMET00451 | DBMET00451 | |
| 0.071 | 0.104 | 0.082 | D-Ala-D-Ala ligase inhibitor | 0.082 0.062 DBMET00451 | DBMET00451 | |
| 0.049 | 0.083 | 0.068 | Catalase inhibitor | 0.068 0.056 DBMET00451 | DBMET00451 | |
| 0.021 | 0.055 | 0.027 | Hedgehog signaling activator | 0.027 0.02 DBMET00451 | DBMET00451 | |
| 0.129 | 0.163 | 0.17 | Insulin sensitizer | 0.17 0.107 DBMET00451 | DBMET00451 | |
| 0.037 | 0.072 | 0.066 | Aconitate hydratase inhibitor | 0.066 0.021 DBMET00451 | DBMET00451 | |
| 0.072 | 0.109 | 0.097 | Expectorant | 0.097 0.072 DBMET00451 | DBMET00451 | |
| 0.035 | 0.075 | 0.098 | Alcohol oxidase inhibitor | 0.098 0.018 DBMET00451 | DBMET00451 | |
| 0.072 | 0.112 | 0.118 | Lanosterol 14 alpha demethylase inhibitor | 0.118 0.033 DBMET00451 | DBMET00451 | |
| 0.038 | 0.08 | 0.055 | NMDA receptor glycine site agonist | 0.055 0.051 DBMET00451 | DBMET00451 | |
| 0.194 | 0.236 | 0.323 | Antibacterial | 0.323 0.119 DBMET00451 | DBMET00451 | |
| 0.043 | 0.086 | 0.102 | Purinergic P2X1 antagonist | 0.102 0.016 DBMET00451 | DBMET00451 | |
| 0.052 | 0.096 | 0.061 | Transcription factor RelA inhibitor | 0.061 0.052 DBMET00451 | DBMET00451 | |
| 0.026 | 0.071 | 0.043 | Guanylate cyclase inhibitor | 0.043 0.029 DBMET00451 | DBMET00451 | |
| 0.028 | 0.074 | 0.056 | Ornithine carbamoyltransferase inhibitor | 0.056 0.034 DBMET00451 | DBMET00451 | |
| 0.02 | 0.066 | 0.026 | Thymidine kinase (Herpes simplex virus 1) inhibitor | 0.026 0.021 DBMET00451 | DBMET00451 | |
| 0.003 | 0.049 | 0.007 | DNA topoisomerase III inhibitor | 0.007 0.006 DBMET00451 | DBMET00451 | |
| 0.083 | 0.13 | 0.102 | Photosensitizer | 0.102 0.085 DBMET00451 | DBMET00451 | |
| 0.047 | 0.097 | 0.081 | Glutamate decarboxylase inhibitor | 0.081 0.044 DBMET00451 | DBMET00451 | |
| 0.166 | 0.216 | 0.214 | Insulysin inhibitor | 0.214 0.137 DBMET00451 | DBMET00451 | |
| 0.016 | 0.068 | 0.025 | Glutamate (mGluR1) agonist | 0.025 0.016 DBMET00451 | DBMET00451 | |
| 0.027 | 0.079 | 0.043 | Thymidine kinase inhibitor | 0.043 0.025 DBMET00451 | DBMET00451 | |
| 0.087 | 0.139 | 0.109 | Cathepsin H inhibitor | 0.109 0.091 DBMET00451 | DBMET00451 | |
| 0.109 | 0.162 | 0.157 | Melanin inhibitor | 0.157 0.073 DBMET00451 | DBMET00451 | |
| 0.047 | 0.102 | 0.073 | Aminopeptidase I inhibitor | 0.073 0.049 DBMET00451 | DBMET00451 | |
| 0.098 | 0.155 | 0.126 | Vanilloid 1 agonist | 0.126 0.073 DBMET00451 | DBMET00451 | |
| 0.084 | 0.141 | 0.136 | Lipid peroxidase inhibitor | 0.136 0.078 DBMET00451 | DBMET00451 | |
| 0.011 | 0.071 | 0.029 | Uridine phosphorylase inhibitor | 0.029 0.018 DBMET00451 | DBMET00451 | |
| 0.05 | 0.113 | 0.089 | Ornithine decarboxylase inhibitor | 0.089 0.057 DBMET00451 | DBMET00451 | |
| 0.165 | 0.228 | 0.215 | Antithrombotic | 0.215 0.16 DBMET00451 | DBMET00451 | |
| 0.053 | 0.116 | 0.07 | S-adenosyl-L-methionine decarboxylase inhibitor | 0.07 0.059 DBMET00451 | DBMET00451 | |
| 0.025 | 0.089 | 0.037 | Glutamate (mGluR8) agonist | 0.037 0.029 DBMET00451 | DBMET00451 | |
| 0.04 | 0.107 | 0.061 | NMDA receptor agonist | 0.061 0.046 DBMET00451 | DBMET00451 | |
| 0.028 | 0.095 | 0.043 | 3-Hydroxyanthranilate 3,4-dioxygenase inhibitor | 0.043 0.026 DBMET00451 | DBMET00451 | |
| 0.039 | 0.11 | 0.076 | Histidine decarboxylase inhibitor | 0.076 0.045 DBMET00451 | DBMET00451 | |
| 0.105 | 0.177 | 0.146 | Interferon gamma antagonist | 0.146 0.084 DBMET00451 | DBMET00451 | |
| 0.067 | 0.145 | 0.116 | Cholesterol synthesis inhibitor | 0.116 0.069 DBMET00451 | DBMET00451 | |
| 0.02 | 0.102 | 0.034 | Glutamate (mGluR3) agonist | 0.034 0.019 DBMET00451 | DBMET00451 | |
| 0.046 | 0.13 | 0.072 | GABA aminotransferase inhibitor | 0.072 0.058 DBMET00451 | DBMET00451 | |
| 0.074 | 0.159 | 0.099 | TRPA1 agonist | 0.099 0.089 DBMET00451 | DBMET00451 | |
| 0.105 | 0.191 | 0.14 | Ca2+/calmodulin-dependent protein kinase kinase B inhibitor | 0.14 0.093 DBMET00451 | DBMET00451 | |
| 0.035 | 0.122 | 0.11 | Phenylalanine 4-hydroxylase inhibitor | 0.11 0.021 DBMET00451 | DBMET00451 | |
| 0.09 | 0.178 | 0.14 | Mannose-6-phosphate isomerase inhibitor | 0.14 0.073 DBMET00451 | DBMET00451 | |
| 0.019 | 0.111 | 0.036 | GABA uptake inhibitor | 0.036 0.033 DBMET00451 | DBMET00451 | |
| 0.049 | 0.141 | 0.078 | Keratolytic | 0.078 0.052 DBMET00451 | DBMET00451 | |
| 0.109 | 0.203 | 0.187 | Immunostimulant | 0.187 0.129 DBMET00451 | DBMET00451 | |
| 0.052 | 0.147 | 0.079 | Potassium channel activator | 0.079 0.077 DBMET00451 | DBMET00451 | |
| 0.06 | 0.156 | 0.09 | Granulocyte macrophage colony stimulating factor agonist | 0.09 0.052 DBMET00451 | DBMET00451 | |
| 0.057 | 0.153 | 0.079 | MAP kinase kinase 7 inhibitor | 0.079 0.048 DBMET00451 | DBMET00451 | |
| 0.047 | 0.147 | 0.085 | Aminopeptidase B inhibitor | 0.085 0.077 DBMET00451 | DBMET00451 | |
| 0.04 | 0.145 | 0.065 | Interferon inducer | 0.065 0.043 DBMET00451 | DBMET00451 | |
| 0.049 | 0.155 | 0.089 | Alcohol dehydrogenase inhibitor | 0.089 0.066 DBMET00451 | DBMET00451 | |
| 0.058 | 0.167 | 0.087 | Carbonic anhydrase III inhibitor | 0.087 0.079 DBMET00451 | DBMET00451 | |
| 0.059 | 0.174 | 0.142 | Amylase inhibitor | 0.142 0.068 DBMET00451 | DBMET00451 | |
| 0.066 | 0.184 | 0.118 | DOPA decarboxylase inhibitor | 0.118 0.048 DBMET00451 | DBMET00451 | |
| 0.041 | 0.169 | 0.076 | Interferon agonist | 0.076 0.059 DBMET00451 | DBMET00451 | |
| 0.004 | 0.144 | 0.01 | CXC chemokine 3 receptor agonist | 0.01 0.005 DBMET00451 | DBMET00451 | |
| 0.005 | 0.145 | 0.035 | Cathepsin S inhibitor | 0.035 0.007 DBMET00451 | DBMET00451 | |
| 0.045 | 0.192 | 0.093 | HIV-1 integrase (Overall Integration) inhibitor | 0.093 0.062 DBMET00451 | DBMET00451 | |
| 0.051 | 0.203 | 0.094 | Xanthine oxidase inhibitor | 0.094 0.066 DBMET00451 | DBMET00451 | |
| 0.106 | 0.28 | 0.168 | Superoxide dismutase inhibitor | 0.168 0.159 DBMET00451 | DBMET00451 | |
| 0.095 | 0.275 | 0.139 | Phospholipase C inhibitor | 0.139 0.13 DBMET00451 | DBMET00451 | |
| 0.021 | 0.229 | 0.479 | DNA gyrase subunit A inhibitor | 0.479 0.001 DBMET00451 | DBMET00451 | |
| 0.094 | 0.305 | 0.241 | Lipoxygenase inhibitor | 0.241 0.106 DBMET00451 | DBMET00451 | |
| 0.117 | 0.523 | 0.235 | Calcium channel L-type activator | 0.235 0.222 DBMET00451 | DBMET00451 | |
| 0.011 | 0.423 | 0.228 | Potassium channel Kv1.5 blocker | 0.228 0.005 DBMET00451 | DBMET00451 | |
| 0.02 | 0.473 | 0.162 | Phosphodiesterase inhibitor | 0.162 0.051 DBMET00451 | DBMET00451 | |
| 0.01 | 0.511 | 0.465 | DNA topoisomerase IV inhibitor | 0.465 0.002 DBMET00451 | DBMET00451 | |
| 0.007 | 0.649 | 0.234 | DNA gyrase inhibitor | 0.234 0.004 DBMET00451 | DBMET00451 | |
| 0.004 | 0.661 | 0.061 | Phosphodiesterase X inhibitor | 0.061 0.02 DBMET00451 | DBMET00451 | |
| 0.004 | 0.661 | 0.061 | Phosphodiesterase 10A inhibitor | 0.061 0.02 DBMET00451 | DBMET00451 | |
| 0.005 | 0.78 | 0.411 | Cyclooxygenase 2 inhibitor | 0.411 0.005 DBMET00451 | DBMET00451 | |
| 0.005 | 0.79 | 0.798 | Cyclooxygenase 1 inhibitor | 0.798 0.003 DBMET00451 | DBMET00451 | |
| 0.005 | 0.804 | 0.478 | Topoisomerase II inhibitor | 0.478 0.007 DBMET00451 | DBMET00451 | |
| 0.005 | 0.804 | 0.455 | Cyclooxygenase inhibitor | 0.455 0.005 DBMET00451 | DBMET00451 | |
| 0.014 | 0.841 | 0.486 | Immunosuppressant | 0.486 0.037 DBMET00451 | DBMET00451 | |
| 0.004 | 0.9 | 0.654 | 5-Lipoxygenase inhibitor | 0.654 0.003 DBMET00451 | DBMET00451 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |